Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stéphanie Gillet"'
Autor:
Stephanie Picandet, Daniel Masseau, Stéphanie Gillet-Hladky, Dominique Rigal, Karine Duperrier, Jacques Bienvenu, Virginie Mathias, Miranda Camila de Carvalho, Janine Bernaud
Publikováno v:
International Immunopharmacology. 8:1151-1163
Dendritic cells (DCs) are the most potent antigen presenting cells of the immune system as they can act as initiators, stimulators and regulators of the immune response. Human DCs are most commonly generated for clinical use by in vitro differentiati
Autor:
Christine Bendahou, Dominique Rigal, Stéphanie Gillet-Hladky, Christian Bloy, Camila Miranda de Carvalho, Janine Bernaud
Publikováno v:
Transplantation. 82(7)
BACKGROUND Rabbit antithymocyte globulin (rATG) is a polyclonal mixture of immunoglobulin (Ig) G. It is used to prevent graft rejection and also graft versus host disease after transplantation. Its effect on lymphocyte function has been widely studie
Autor:
Jacques Izopet, Alain Bicart See, Daniel Vittecoq, Marc-Antoine Valantin, Philippe Morlat, Anne Gervais, François Rouges, Karl Barange, Philippe Sogni, Marion Mora, Patrizia Carrieri, Lawrence Serfaty, Caroline Lascoux-Combe, Dominique Salmon, François Dabis, Claudine Duvivier, Jean Delaune, Maria Winnock, Laurence Merchadou, Philippe Bonnard, Karine Lacombe, Eric Rosenthal, Marc-Arthur Loko, Stéphanie Gillet, Cécile Goujard, Bruno Spire, Isabelle Poizot-Martin, Elodie Pambrun, Firouzé Bani-Sadr, Yves Benhamou, Didier Neau
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2006, 10 (1), pp.303. ⟨10.1186/1471-2334-10-303⟩
BMC Infectious Diseases, BioMed Central, 2006, 10 (1), pp.303. <10.1186/1471-2334-10-303>
BMC Infectious Diseases, 2006, 10 (1), pp.303. ⟨10.1186/1471-2334-10-303⟩
BMC Infectious Diseases, Vol 10, Iss 1, p 303 (2010)
BMC Infectious Diseases, BioMed Central, 2006, 10 (1), pp.303. ⟨10.1186/1471-2334-10-303⟩
BMC Infectious Diseases, BioMed Central, 2006, 10 (1), pp.303. <10.1186/1471-2334-10-303>
BMC Infectious Diseases, 2006, 10 (1), pp.303. ⟨10.1186/1471-2334-10-303⟩
BMC Infectious Diseases, Vol 10, Iss 1, p 303 (2010)
Background In France, it is estimated that 24% of HIV-infected patients are also infected with HCV. Longitudinal studies addressing clinical and public health questions related to HIV-HCV co-infection (HIV-HCV clinical progression and its determinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d3e0b239906f97e8f2cc423e4fa201
https://hal-pasteur.archives-ouvertes.fr/pasteur-01070193/file/1471-2334-10-303.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-01070193/file/1471-2334-10-303.pdf